|
|
|
Insider
Information: |
Frost Phillip Md Et Al |
Relationship: |
10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
4,087,084 |
|
Indirect Shares
|
329,334,862 |
|
|
Direct
Value |
$12,696,939 |
|
|
Indirect Value
|
$497,096,139 |
|
|
Total
Shares |
333,421,946 |
|
|
Total
Value |
$509,793,078 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
270.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ladenburg Thalmann Financial Ser... |
LTS |
Director, 10% Owner |
2003-07-11 |
0 |
2007-01-08 |
48,785,909 |
Premium* |
|
Northrop Grumman Corp |
NOC |
Director |
2009-03-31 |
18,357 |
2009-03-31 |
73,199 |
Premium* |
|
Continucare Corp |
CNU |
Director, 10% Owner |
2007-07-30 |
400,000 |
2007-07-30 |
23,929,801 |
Premium* |
|
Asensus Surgical Inc |
ASXC |
10% Owner |
|
0 |
2013-03-22 |
13,122,346 |
Premium* |
|
Non Invasive Monitoring Systems ... |
NIMU |
10% Owner |
|
0 |
2006-10-16 |
11,403,281 |
Premium* |
|
Protalix Biotherapeutics |
PLX |
Director, 10% Owner |
|
0 |
2006-12-31 |
7,645,228 |
Premium* |
|
Castle Brands Inc |
ROX |
Director |
2007-05-08 |
599,776 |
2007-05-08 |
75,400 |
Premium* |
|
Opko Health Inc |
OPK |
CEO & Chairman, Direct... |
2020-04-02 |
3,068,951 |
2020-04-02 |
218,398,871 |
Premium* |
|
Winston Pharmaceuticals Inc |
WPHM |
10% Owner |
|
0 |
2008-02-25 |
5,900,827 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
75 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NOC |
Northrop Grumman Corp |
Director |
|
2007-03-30 |
4 |
A |
$74.22 |
$56,407 |
I/I |
760 |
5,106 |
0 |
- |
|
NOC |
Northrop Grumman Corp |
Director |
|
2007-06-30 |
4 |
A |
$77.87 |
$57,312 |
I/I |
736 |
5,842 |
0 |
- |
|
NOC |
Northrop Grumman Corp |
Director |
|
2007-09-28 |
4 |
A |
$78.00 |
$55,614 |
I/I |
713 |
6,555 |
0 |
- |
|
NOC |
Northrop Grumman Corp |
Director |
|
2007-12-31 |
4 |
A |
$78.64 |
$53,868 |
I/I |
685 |
7,240 |
0 |
- |
|
NOC |
Northrop Grumman Corp |
Director |
|
2008-03-31 |
4 |
A |
$77.81 |
$52,444 |
I/I |
674 |
7,914 |
0 |
- |
|
NOC |
Northrop Grumman Corp |
Director |
|
2008-05-07 |
4 |
D |
$74.70 |
$154,853 |
D/D |
(2,073) |
12,357 |
0 |
- |
|
NOC |
Northrop Grumman Corp |
Director |
|
2008-05-07 |
4 |
OE |
$51.63 |
$154,890 |
D/D |
3,000 |
14,430 |
0 |
- |
|
NOC |
Northrop Grumman Corp |
Director |
|
2008-06-30 |
4 |
A |
$66.90 |
$46,094 |
I/I |
689 |
8,603 |
0 |
- |
|
NOC |
Northrop Grumman Corp |
Director |
|
2008-09-30 |
4 |
A |
$60.54 |
$43,649 |
I/I |
721 |
9,324 |
0 |
- |
|
NOC |
Northrop Grumman Corp |
Director |
|
2008-12-31 |
4 |
A |
$45.04 |
$40,671 |
I/I |
903 |
10,227 |
0 |
- |
|
NOC |
Northrop Grumman Corp |
Director |
|
2009-02-24 |
4 |
OE |
$35.50 |
$223,140 |
D/D |
6,000 |
18,357 |
0 |
- |
|
NOC |
Northrop Grumman Corp |
Director |
|
2009-03-31 |
4 |
A |
$43.64 |
$45,822 |
I/I |
1,050 |
11,277 |
0 |
- |
|
OPK |
Opko Health Inc |
10% Owner |
|
2007-02-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
12,697,290 |
|
- |
|
OPK |
Opko Health Inc |
CEO & Chariman |
|
2007-03-27 |
4 |
A |
$0.00 |
$0 |
I/I |
36,518,923 |
36,518,923 |
0 |
- |
|
OPK |
Opko Health Inc |
CEO & Chairman |
|
2007-07-12 |
4 |
B |
$3.69 |
$104,315 |
I/I |
28,200 |
36,547,123 |
2.64 |
- |
|
OPK |
Opko Health Inc |
CEO & Chairman |
|
2007-07-13 |
4 |
B |
$1.80 |
$7,291,452 |
I/I |
4,042,060 |
40,589,183 |
2.64 |
- |
|
OPK |
Opko Health Inc |
CEO & Chairman |
|
2010-02-25 |
4 |
B |
$1.96 |
$19,892 |
I/I |
10,000 |
97,309,552 |
2.56 |
- |
|
OPK |
Opko Health Inc |
CEO & Chairman |
|
2010-03-24 |
4 |
B |
$2.00 |
$20,205 |
I/I |
10,000 |
97,422,052 |
2.56 |
- |
|
OPK |
Opko Health Inc |
CEO & Chairman |
|
2020-04-02 |
4 |
B |
$1.15 |
$581,185 |
I/I |
500,000 |
188,271,694 |
2.64 |
% |
|
PLX |
Protalix Biotherapeutics |
officerTitle |
|
2005-11-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,965,428 |
|
- |
|
PLX |
Protalix Biotherapeutics |
Director |
|
2006-12-31 |
4 |
A |
$0.00 |
$0 |
I/I |
7,348,675 |
7,645,228 |
0 |
- |
|
WPHM |
Winston Pharmaceuticals I... |
10% Owner |
|
2007-03-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,886,897 |
|
- |
|
WPHM |
Winston Pharmaceuticals I... |
10% Owner |
|
2007-12-06 |
4 |
B |
$1.39 |
$15,395 |
I/I |
10,000 |
5,896,897 |
1.5 |
- |
|
WPHM |
Winston Pharmaceuticals I... |
10% Owner |
|
2008-02-22 |
4 |
B |
$1.35 |
$4,777 |
I/I |
3,430 |
5,900,327 |
1.42 |
- |
|
WPHM |
Winston Pharmaceuticals I... |
10% Owner |
|
2008-02-25 |
4 |
B |
$1.45 |
$725 |
I/I |
500 |
5,900,827 |
1.42 |
- |
|
75 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|